Indeed, the beneficial effects of NSAIDs on memory performance in transgenic mouse models of AD have been proposed to relate directly to their blockade of COX activity [102-105,142,143], and not to their ability to lower levels of inflammatory cytokines, TNF-α or IL-1β [144]. The gene discussed is IL1B; the disease is Alzheimer disease.